Statins and diabetes mellitus: risks and benefits
Patients with diabetes mellitus (DM) are at a high risk of cardiovascular events (CVE). Currently, the predominant clinical strategy of the CVE prevention in DM patients is aggressive lowering of low-density lipoprotein cholesterol and blood pressure levels. In this clinical group, statins are among...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2012-12-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/2038 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1839578032124198912 |
|---|---|
| author | O. M. Drapkina O. N. Korneeva A. F. Sheptulina |
| author_facet | O. M. Drapkina O. N. Korneeva A. F. Sheptulina |
| author_sort | O. M. Drapkina |
| collection | DOAJ |
| description | Patients with diabetes mellitus (DM) are at a high risk of cardiovascular events (CVE). Currently, the predominant clinical strategy of the CVE prevention in DM patients is aggressive lowering of low-density lipoprotein cholesterol and blood pressure levels. In this clinical group, statins are among the most widely used pharmacological agents. Recent clinical evidence suggests that statin therapy could be associated with an increased risk of DM. Both clinicians and researchers need to reevaluate the issue of statin safety in the patients at a higher CVE risk. This review focuses on the problem of DM development in statin-treated patients. |
| format | Article |
| id | doaj-art-bf21b96a7a2a4e8bb08c5a5d7f45b5cb |
| institution | Matheson Library |
| issn | 1728-8800 2619-0125 |
| language | Russian |
| publishDate | 2012-12-01 |
| publisher | «SILICEA-POLIGRAF» LLC |
| record_format | Article |
| series | Кардиоваскулярная терапия и профилактика |
| spelling | doaj-art-bf21b96a7a2a4e8bb08c5a5d7f45b5cb2025-08-04T12:50:18Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252012-12-01116859010.15829/1728-8800-2012-6-85-901750Statins and diabetes mellitus: risks and benefitsO. M. Drapkina0O. N. Korneeva1A. F. Sheptulina2I. M. Sechenov First Moscow State Medical University, MoscowI. M. Sechenov First Moscow State Medical University, MoscowI. M. Sechenov First Moscow State Medical University, MoscowPatients with diabetes mellitus (DM) are at a high risk of cardiovascular events (CVE). Currently, the predominant clinical strategy of the CVE prevention in DM patients is aggressive lowering of low-density lipoprotein cholesterol and blood pressure levels. In this clinical group, statins are among the most widely used pharmacological agents. Recent clinical evidence suggests that statin therapy could be associated with an increased risk of DM. Both clinicians and researchers need to reevaluate the issue of statin safety in the patients at a higher CVE risk. This review focuses on the problem of DM development in statin-treated patients.https://cardiovascular.elpub.ru/jour/article/view/2038statinsdiabetes mellituscardiovascular diseasepancreatic β-cells |
| spellingShingle | O. M. Drapkina O. N. Korneeva A. F. Sheptulina Statins and diabetes mellitus: risks and benefits Кардиоваскулярная терапия и профилактика statins diabetes mellitus cardiovascular disease pancreatic β-cells |
| title | Statins and diabetes mellitus: risks and benefits |
| title_full | Statins and diabetes mellitus: risks and benefits |
| title_fullStr | Statins and diabetes mellitus: risks and benefits |
| title_full_unstemmed | Statins and diabetes mellitus: risks and benefits |
| title_short | Statins and diabetes mellitus: risks and benefits |
| title_sort | statins and diabetes mellitus risks and benefits |
| topic | statins diabetes mellitus cardiovascular disease pancreatic β-cells |
| url | https://cardiovascular.elpub.ru/jour/article/view/2038 |
| work_keys_str_mv | AT omdrapkina statinsanddiabetesmellitusrisksandbenefits AT onkorneeva statinsanddiabetesmellitusrisksandbenefits AT afsheptulina statinsanddiabetesmellitusrisksandbenefits |